Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HEB stock: Hemispherx BioPharma, Inc

Current Rating
Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$0.20
Market Cap
10.7M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.06
P/S
42.14
Dividend %
-
P/CF
3.3
P/FCF
-
Op. Cash Flow
-7.9K
FCF
-0.2
Op. Margin
-
Net Margin
-
ROE
-88.00%
ROI
-108.70%
ROA
-55.00%
EPS Growth
37.30%
Current Ratio
1.3
Debt/Equity
20.70%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Digirad Corporation (DRAD) $1.03 - 18.00% 26.8M Strong Buy
Procyon Corp (PCYN) $0.20 - - 2.5M Strong Buy
Biostem Technologies Inc (BSEM) $3.80 - - 33M Strong Buy
Integer Holdings Corp (ITGR) $85.72 - - 2.7B Strong Buy
Premier Inc (PINC) $39.57 - - 5.95B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More